Sortiert nach Labs

Publikationen - sortiert nach Labs

• Takai Y, Hametner S, Riedl C, Misu T, Takahashi T, Suzuki H, Chihara N, Watanabe M, Miyahara H, Yoshida M, Iwasaki Y, Suzuki T, Di Pauli F, Bramow S, Laureys G, Banwell B, Mariotto S, Fujihara K, Aoki M, Bradl M, Lassmann H, Höftberger R (2026) Characteristic patterns of complement deposition in NMOSD, MOGAD, and MS Acta Neuropathol, 151 (1): 13

• Brandl S, Yu Q, Hagenbuchner J, Endmayr V, Höftberger R, Bradl M, Reindl M (2025) Inflammatory transcriptomic signatures in a human cellular NMOSD model reveal upregulation of NF-κB and IL6 pathways Sci Rep, 15 (1)

• Bradl M, Yu Q, Takai Y (2025) The immunological processes behind aquaporin 4-antibody seropositive neuromyelitis optica spectrum disorders Semin Neurol, 78: 101945

• Mader S, Ho S, Wong H, Baier S, Winklmeier S, Riemer C, Rübsamen H, Fernandez I, Gerhards R, Du C, Chuquisana O, Lünemann J, Lux A, Nimmerjahn F, Bradl M*, Kawakami N*, Meinl E* (* shared senior authorship) (2023) Dissection of complement and Fc-receptor-mediated pathomechanisms of autoantibodies to myelin oligodendrocyte glycoprotein PNAS, 120 (13): e2300648120
• Zakani M, Nigritinou M, Ponleitner M, Takai Y, Hofmann D, Hillebrand S, Höftberger R, Bauer J, Lasztoczi B, Misu T, Kasprian G, Rommer P, Bradl M (2023) Paths to hippocampal damage in neuromyelitis optica spectrum disorders Neuropathol Appl Neurobiol, 49 (2)
  | Article (PDF) || Weblink |

• Bradl M (2022) From astrocyte destruction to axon injury: watching lesion evolution in experimental neuromyelitis optica Brain, 145(5): 1581-1583